ATLANTA – A teenage girl with advanced osteosarcoma has had a durable complete remission after receiving CAR T cells targeted to HER2.
From the Editor
The oral tyrosine kinase inhibitor was associated with durable responses and a high progression-free survival rate in patients with refractory or...
Reports from the annual meeting of The Connective Tissue Society held November 14-18, 2018, in Rome.
Reports from the annual meeting of The Connective Tissue Oncology Society held in Rome, November 14-17, 2018 Sarcoma of the Year: Intimal Sarcoma
Sarcoma of the Year: Intimal Sarcoma
Larotrectinib is approved for patients with solid tumors that have progressed following treatment and harbor a NTRK gene fusion without a...
Aberrations in oncogenic pathways and immune modulation influence treatment response in patients with metastatic leiomyosarcoma or liposarcoma.
The partial hold that paused U.S.-based enrollment in clinical trials of tazemetostat has been lifted.